Supernus Pharmaceuticals (SUPN) Return on Assets (2012 - 2026)
Supernus Pharmaceuticals (SUPN) posted quarterly Return on Assets of 0.0% for Q2 2026, little changed year-over-year from 0.0% in Q2 2025, and down 305.67% on a QoQ basis from 0.0% in Q1 2026.
Supernus Pharmaceuticals (SUPN) Return on Assets (2012 - 2026) Analysis & Trends
Supernus Pharmaceuticals has reported Return on Assets for 15 years, with the latest figure at 0.0% in Q2 2026.
- Return on Assets for Q2 2026 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
- Return on Assets eased to 0.0% in Q2 2026, from 0.0% in the prior quarter.
- Over five years, Return on Assets peaked at 0.0% in Q4 2024 and troughed at 0.0% in Q2 2026.
- A 5-year average of 0.0% and a median of 0.0% in 2022 frame the typical range for Return on Assets.
- The largest YoY upside for Return on Assets was 0 bps in 2022 against a maximum downside of 0 bps in 2022.
- A 5-year view of Return on Assets shows it stood at 0.0% in 2022, then tumbled by 97 bps to 0.0% in 2023, then surged by 5337 bps to 0.0% in 2024, then slumped by 149 bps to 0.0% in 2025, then plunged by 174 bps to 0.0% in 2026.
- Per Business Quant data, the three most recent Return on Assets figures were 0.0% in Q2 2026, 0.0% in Q1 2026, and 0.0% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 0.00% |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 0.00% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 0.00% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 0.00% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 0.00% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 0.00% |
| 10 | Supernus Pharmaceuticals | 2.75 Bn | 2.38 Bn | 185.39 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00% |
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |